Upstream Bio, Inc.
UPB
$8.56
-$0.09-1.04%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -27.27M | -21.24M | -15.99M | -12.79M | -10.89M |
| Total Depreciation and Amortization | 43.00K | 49.00K | 14.00K | 13.00K | 13.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.03M | 2.90M | 1.30M | -1.26M | -2.82M |
| Change in Net Operating Assets | -14.97M | -1.32M | 717.00K | 1.24M | -3.86M |
| Cash from Operations | -41.17M | -19.61M | -13.96M | -12.80M | -17.56M |
| Capital Expenditure | -- | -185.00K | -326.00K | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -213.38M | 42.09M | 1.74M | -51.40M | 13.85M |
| Cash from Investing | -213.38M | 41.91M | 1.41M | -51.40M | 13.85M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 272.75M | 19.00K | 56.00K | 9.39M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | 75.00K | 0.00 | 74.96M | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -34.00K | -2.18M | -1.66M | -66.50K | -- |
| Cash from Financing | -34.00K | 270.65M | -1.64M | 74.95M | 9.39M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -254.58M | 292.94M | -14.19M | 10.75M | 5.68M |